Second‐line immunotherapy in new onset refractory status epilepticus.

MLA

Hanin, Aurélie, et al. “Second‐line Immunotherapy in New Onset Refractory Status Epilepticus.” Epilepsia (Series 4), vol. 65, no. 5, May 2024, pp. 1203–23. EBSCOhost, https://doi.org/10.1111/epi.17933.

APA

Hanin, A., Muscal, E., & Hirsch, L. J. (2024). Second‐line immunotherapy in new onset refractory status epilepticus. Epilepsia (Series 4), 65(5), 1203–1223. https://doi.org/10.1111/epi.17933

Chicago

Hanin, Aurélie, Eyal Muscal, and Lawrence J. Hirsch. 2024. “Second‐line Immunotherapy in New Onset Refractory Status Epilepticus.” Epilepsia (Series 4) 65 (5): 1203–23. doi:10.1111/epi.17933.